CGMS | GOF | CGMS / GOF | |
Gain YTD | 3.999 | 5.325 | 75% |
Net Assets | 2.86B | 1.8B | 158% |
Total Expense Ratio | 0.39 | 1.62 | 24% |
Turnover | 39.00 | 30.00 | 130% |
Yield | 5.71 | 7.55 | 76% |
Fund Existence | 3 years | 18 years | - |
CGMS | GOF | |
---|---|---|
RSI ODDS (%) | 5 days ago38% | 5 days ago71% |
Stochastic ODDS (%) | 5 days ago40% | 5 days ago76% |
Momentum ODDS (%) | N/A | 5 days ago79% |
MACD ODDS (%) | N/A | 5 days ago84% |
TrendWeek ODDS (%) | 5 days ago71% | 5 days ago88% |
TrendMonth ODDS (%) | 5 days ago68% | 5 days ago90% |
Advances ODDS (%) | 18 days ago69% | 5 days ago86% |
Declines ODDS (%) | N/A | 22 days ago76% |
BollingerBands ODDS (%) | 5 days ago36% | 5 days ago79% |
Aroon ODDS (%) | 5 days ago62% | 5 days ago90% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GTLLX | 29.03 | 0.35 | +1.22% |
Glenmede Disciplined US Growth Eq Ptf | |||
RGACX | 79.90 | 0.78 | +0.99% |
American Funds Growth Fund of Amer R3 | |||
GRLLX | 19.87 | 0.18 | +0.91% |
Goldman Sachs Enhanced U.S. Equity R | |||
HLMOX | 8.63 | 0.04 | +0.47% |
Harding Loevner Frontier Emerg Mkts Inv | |||
SVFAX | 76.58 | -0.29 | -0.38% |
Smead Value A |
A.I.dvisor tells us that CGMS and DBD have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CGMS and DBD's prices will move in lockstep.
Ticker / NAME | Correlation To CGMS | 1D Price Change % | ||
---|---|---|---|---|
CGMS | 100% | -0.04% | ||
DBD - CGMS | 24% Poorly correlated | +2.16% | ||
NFE - CGMS | 16% Poorly correlated | +5.67% |